Heart Valve Market, By Type (Mechanical Heart Valves (Aortic Valves and Mitral Valves), Biological Heart Valves (Aortic Valves, Mitral Valves, Pulmonary Valves, and Tricuspid Valves), and Transcatheter Heart Valves (Aortic Valves, Mitral Valves, and Pulmonary Valves)), By End User (Hospitals and Ambulatory Surgical Center), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI71619 | Publish Date: March 2024 | No. of Pages: 180

Global Heart Valve Market Market Companies

  • Boston Scientific Corporation
  • Abbott Laboratories Inc.
  • TTK Healthcare Limited
  • Medtronic, Inc.
  • Sorin Group
  • Lepu Medical Technology CO. Ltd.
  • Edward Lifesciences Corporation
  • CryoLife Inc.
  • JenaValve Technology Inc.
  • Neovasc Inc.
  • Micro Interventional Devices Inc.

Recent News:

  • Aster Medcity created the "Aster Advanced Heart Valve Centre," a specialized division under Aster Cardiac Sciences, in May 2023. This specialized department offers a broad range of treatments, including medications, minimally invasive techniques, and surgical procedures like valve replacement or repair. Its primary focus is on valvular heart disease diagnosis and treatment. The center offers non-cardiology services from Neurology, Nephrology, Vascular and General Surgery, Infection Control, Stroke and Elderly care, and Psychiatry. It also has a Heart Failure Clinic and a Heart Valve Clinic.
  • Abbott announced the launch of NavitorTM, a next-generation transcatheter aortic valve implantation (TAVI) technology, in December 2022. This implies that this minimally invasive procedure is now available to Indian patients with severe aortic stenosis who are at high or extreme surgical risk. Transcatheter aortic valve replacement, or TAVI, therapies are being advanced by the company using devices like the Navitor valve, which has a unique design that prevents blood leakage around the valve. The Navitor TAVI system, the newest model in the company's wide range of structural heart transcatheter, offers patients and physicians less invasive options for treating heart conditions.